TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
IrenePharma Oy
Closing information (x1000 DKK)
Closing information | 2017/10 | 2016/10 | 2015/10 |
Turnover |
14,458
|
12,981
|
11,337 |
Financial expenses |
15
![]() |
15
|
0 |
Earnings before taxes |
3,163
|
2,648
|
2,297 |
Total assets |
9,770
|
8,257
|
6,571 |
Current assets |
201
|
104
|
1,290 |
Current liabilities |
766
|
670
|
612 |
Equity capital |
9,011
|
7,588
|
5,959 |
- share capital |
22
![]() |
22
![]() |
22 |
Financial ratios
Fiscal year | 2017/10 | 2016/10 | 2015/10 |
Solvency |
92.2%
|
91.9%
|
90.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
21.9%
|
20.4%
|
20.3% |
Return on assets (ROA) |
32.5%
|
32.3%
|
35.0% |
Current ratio |
26.2%
|
15.5%
|
210.8% |
Return on equity (ROE) |
35.1%
|
34.9%
|
38.5% |
Change turnover |
1,473
|
1,674
|
276 |
Change turnover % |
11%
|
15%
|
2% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/10 | 2016/10 | 2015/10 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.